Designing Inhibitors for the SARS CoV Main Protease as Anti-SARS Drugs
Severe Acute Respiratory Syndrome (SARS) is a serious respiratory illness reported in parts of Asia and Canada. A novel coronavirus (CoV) has been isolated and identified as the cause of the SARS for which there is currently no effective treatment. Given the epidemic, the rapid development of effica...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
McGill University
2020-12-01
|
Series: | McGill Journal of Medicine |
Subjects: | |
Online Access: | https://mjm.mcgill.ca/article/view/377 |